Navigation Links
Xanthus Presents Novel Approach for Autoimmune Disease Reversal,with Symadex

CAMBRIDGE, Mass.--(BUSINESS WIRE)--May 3, 2007 - Xanthus Pharmaceuticals, Inc today presented data demonstrating that Symadex(TM) reversed the clinical and pathological signs of chronic disease in an animal model for multiple sclerosis. The presentation was made by Stephen J. Karlik, Ph.D., Professor of Diagnostic Radiology at the University of Western Ontario, London, Ontario, together with researchers from Xanthus in a poster session at the 59th American Academy of Neurology Meeting in Boston, MA.

Using a model of experimental autoimmune encephalomyelitis (EAE) that is designed to represent multiple sclerosis, Dr. Karlik tested Symadex for its effect on both acute and chronic disease. In the acute EAE model, animals treated with Symadex substantially recovered while in control animals the disease symptoms and damage remained unchanged. In chronic EAE disease models, clinical and pathological disease reversal and tissue recovery were observed with Symadex treatment. At the same time, Symadex did not affect circulating immune cell numbers, suggesting that it does not act as a general immunosuppressant.

"Symadex' ability to reverse chronic autoimmune disease in this animal model is notable. The study results suggest this activity may result from inhibiting macrophage function rather than inhibiting T cell function. This mechanism is novel in my experience," said Dr. Karlik.

"We now have a significant body of promising preclinical data supporting the use of Symadex in multiple autoimmune indications. We believe this represents a strong partnering opportunity for our Company, and we are preparing to initiate a human proof-of-principle trial with Symadex in autoimmune disease," stated Richard T. Dean, Ph.D., Xanthus' Chief Executive Officer.

About Symadex(TM)

Symadex (formerly C-1311) is the lead compound from a new series of agents, the imidazoacridinones, which have been shown to be po
'"/>




Page: 1 2 3

Related medicine technology :

1. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
2. European Society for Medical Oncology (ESMO) Presents Data from the Clinical Trial of MediGenes Cancer-Killing Virus in Press Conference
3. Cytogen Presents Phase 1 Data Showing Promising Antitumor Activity and Safety Profile of Quadramet at International Myeloma Workshop
4. SemBioSys Presents Positive Insulin Data at the American Diabetes Association Conference
5. Tranzyme Pharma Presents Initial Phase IIa Data for its Novel Ghrelin Agonist, TZP-101, in Patients with Diabetic Gastroparesis
6. Novagali Pharma Presents at AACO the Results of its Pivotal Phase III Clinical Trial of Vekacia in Children Suffering From Vernal Keratoconjunctivitis
7. BioLife Solutions Presents Data on CryoStor at International Society for Cellular Therapy Annual Meeting
8. Genaera Presents Preclinical Data on Trodusquemine (MSI-1436) for the Treatment of Obesity at the American Diabetes Association 67th Scientific Session
9. Elixir Pharmaceuticals Presents Preclinical Data Highlighting Its Ghrelin Antagonist Program at the American Diabetes Associations Annual Meeting
10. DiObex Presents Phase 2a Data of DIO-902 Demonstrating Trends of Improved Glycemic Control and Significant Reductions of LDL-Cholesterol and C-Reactive Protein
11. BioCryst Presents Phase I Peramivir Data at the Options for the Control of Influenza Conference
Post Your Comments:
(Date:3/2/2015)...  Vivex Biomedical, Inc., a leading processor of human ... today that it hired Lou Barnes as ... Vivex Biomedical formed UMTB Biomedical as a wholly-owned subsidiary ... in November 2014. UMTB is the oldest tissue bank ... twenty-five year veteran of the tissue banking industry, having ...
(Date:3/2/2015)... -- Akron Children,s Hospital has been designated a Diagnostic Imaging ... Radiology (ACR), making it the first hospital in ... in the United States to ... the ACR as a DICOE provides validation that our ... national benchmarks," says Dr. Michael Rubin , chairman, ...
(Date:3/2/2015)... 2, 2015  Kush Bottles, North ... solutions for the marijuana industry, announced today that ... been nominated for a 2015 Excellence in Entrepreneurship ... Award is designed to recognize individuals who exemplify ... their creativity and determination, have established and nurtured ...
Breaking Medicine Technology:Vivex Biomedical, Inc. Announces New Chief Operating Officer of Tissue Bank 2Vivex Biomedical, Inc. Announces New Chief Operating Officer of Tissue Bank 3Akron Children's designated ACR Diagnostic Imaging Center of Excellence 2Kush Bottles CEO, Nicholas Kovacevich, Nominated for 2015 "Excellence in Entrepreneurship Award" 2
(Date:3/2/2015)... Wants and Needs ” was featured on NewsWatch as ... and coolest mobile applications on the iOS, Android, and ... host of NewsWatch, conducted the app review and shared ... , Whether a person needs help re-orienting or prioritizing ... allows people to enter and track wants, both good ...
(Date:3/2/2015)... 2015 Doctors in Novara, Italy have ... predictor of outcomes for people with mesothelioma than other ... of the new study on the Surviving Mesothelioma website. ... of Eastern Piedmont followed the cases of 172 ... excess lung fluid. , “Persistent lung expansion after ...
(Date:3/2/2015)... Robins & Morton Celebrates Women In Construction , ... Week (March 1-7, sponsored by the National Association of ... Month, Robins & Morton is recognizing several women whose ... construction industry as a whole. From the craft professionals, ... in between, each woman has a story to share. ...
(Date:3/2/2015)... March 02, 2015 New York ... Unplugged™—will be delivering a plenary address entitled Finding ... the Art of Healing and Recovery at this ... Behavioral Healthcare Executive Summit (BHES).     , With more ... songs have been recorded by some of the ...
(Date:3/2/2015)... (PRWEB) March 02, 2015 Representatives ... it has officially launched a multivitamin supplement that’s ... of product development for BNatrl, said the multivitamin, ... from Olympic and other world-class athletes. , "Being ... use this pure whole food multivitamin to improve ...
Breaking Medicine News(10 mins):Health News:An Application to Evaluate Priorities Was Featured on NewsWatch Television on January 30, 2015 2Health News:New Research Links Talc Treatment Response with Mesothelioma Prognosis, According to Surviving Mesothelioma 2Health News:Robins & Morton Recognizes Women In Construction 2Health News:Richie Supa Announced as a Plenary Speaker at NCAD 2015 2Health News:Bnatrl Launches Multivitamin Supplement for Runners 2
... FindingsBAYSIDE, N.Y., May 28 Once every five ... and medical experts on Tourette Syndrome (TS) -- ... and sounds -- convene to disseminate and share ... condition.As part of its basic mission to identify ...
... than 20 pounds , , THURSDAY, May 28 (HealthDay News) ... pregnancy to between 11 and 20 pounds to safeguard ... newly updated expert guidelines. , That level of gestational ... pregnant women and reflects the concern over the rising ...
... Associate Professor and Director of Biomaterials Research at ... Dentistry, has been awarded a grant in the ... the National Institutes of Health to develop new ... composites, bonding agents, and sealants. Currently most dental ...
... TRAVERSE CITY, Mich., May 28 Versus Technology, Inc. ("Versus" or ... for its second fiscal quarter ended April 30, 2009, a ... quarter of the prior year. Revenues for the six ... for the six months ended April 30, 2008, a 3.5% ...
... Inc. (Nasdaq: STRM ) today announced ... Company,s document workflow solutions will be integrated into ... within an additional leading Canadian healthcare region. Integrating ... view into a patient,s complete history of care ...
... 28 Aventis Pharmaceutical Inc., a wholly owned subsidiary of ... $95.5 million to settle allegations that it violated the False ... its Medicaid Drug Rebate obligations, the Justice Department announced today. ... The settlement resolves allegations that between 1995 ...
Cached Medicine News:Health News:5th International Scientific Symposium on Tourette Syndrome to Focus on Latest Research and Treatment 2Health News:5th International Scientific Symposium on Tourette Syndrome to Focus on Latest Research and Treatment 3Health News:Experts Urge Less Weight Gain for Obese Women in Pregnancy 2Health News:Experts Urge Less Weight Gain for Obese Women in Pregnancy 3Health News:Versus Technology Announces Second Quarter Results 2Health News:Versus Technology Announces Second Quarter Results 3Health News:Versus Technology Announces Second Quarter Results 4Health News:Versus Technology Announces Second Quarter Results 5Health News:Versus Technology Announces Second Quarter Results 6Health News:Versus Technology Announces Second Quarter Results 7Health News:Streamline Health Document Workflow Solution to be Integrated Into Electronic Medical Records System for Leading Canadian Healthcare Region 2Health News:Streamline Health Document Workflow Solution to be Integrated Into Electronic Medical Records System for Leading Canadian Healthcare Region 3Health News:Aventis Pharmaceutical to Pay U.S. $95.5 Million to Settle False Claims Act Allegations 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: